A 663

  • New York Assembly Bill
  • 2021 Regular Session
  • Introduced in Assembly
  • Assembly
  • Senate
  • Governor

Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs

Votes


No votes to display

Actions


May 19, 2022

Assembly

AMEND AND RECOMMIT TO HEALTH

Assembly

PRINT NUMBER 663B

May 06, 2022

Assembly

AMEND (T) AND RECOMMIT TO HEALTH

Assembly

PRINT NUMBER 663A

Jan 05, 2022

Assembly

REFERRED TO HEALTH

Jan 06, 2021

Assembly

REFERRED TO HEALTH

Bill Text

Bill Text Versions Format
A663 PDF HTML
A663A PDF
A663B PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.